Brain Stimulation News
-
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Reduces Symptoms of Acute Withdrawal in Patients with Opioid Use Disorder
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer reviewed manuscript, Transcutaneous Cervical Vagus Nerve Stimulation Reduces Behavioral and Physiological Manifestations of Withdrawal in Patients with Opioid Use Disorder: A Double-Blind, Randomized, Sham-Controlled Pilot Study in the journal, Brain Stimulation. The ...
-
MEDIA - Dessintey on French TV: Tech&Co - BFM Business
Yesterday evening, Nicolas Fournier, co-founder and CEO of Dessintey, was invited by François Sorel in the Tech&Co show on BFM Business. A fascinating introduction of the technological innovation IVS developed by Dessintey, which provides a new therapeutic approach for stroke rehabilitation. IVS: a unique technology dedicated to motor planning and central movement control. Or how ...
-
NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®
NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for “adjunctive use for reducing the frequency of seizures in individuals 18 years of age or older diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary generalization, that are refractory to two or more ...
-
NeuroOne® Medical Technologies Corporation Releases Successful Long-Term Recording Test Data for its Novel Thin Film Platform Electrode Technology
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it successfully completed initial pre-clinical long-term testing of recording capabilities on its platform thin film electrode technology. In test ...
-
The Sunday Times - Sir Richard Branson & co pick their start-ups of 2019
These are the start-ups that most impressed Britain’s top entrepreneurs and investors in 2019. There was a technology theme to the selections, while several on our panel of small business champions picked companies, they claimed were tackling some of the world’s biggest problems by treating Alzheimer’s disease and broadening access to education. ...
-
World leading medical researchers shortlisted for £350,000 engineering research prize
The prize is awarded annually in recognition of outstanding achievement in engineering research in the fields of medical, microwave and radar or laser/optoelectronic engineering, with the prize fund awarded to support further research led by the recipient. This year’s theme is medical engineering and technology. Included in the 2020 shortlist are: Dr Gregoire Courtine is Full Professor ...
-
Newronika Raises an 8.4M EUR Series-A Round
Newronika, a spin-off of world-class neurological research centers Policlinico of Milan and University of Milan, has raised an 8.4 million Euros Series-A round. The investment was led by French venture capital fund Omnes together with existing investors Innogest Capital and Indaco Venture Partners SGR ("Indaco SGR") on behalf of Indaco Ventures I and Atlante Ventures funds. F3F and an undisclosed ...
-
Renishaw opens dedicated healthcare facility at its South Wales site
Global precision engineering company Renishaw plc has announced a new Healthcare Centre of Excellence at its Miskin site, located close to Cardiff, South Wales. The Centre, which was formally opened on 29th September by The Rt Hon Carwyn Jones AM, First Minister of Wales, provides a facility for the manufacture of custom medical devices, as well as education and training for the life sciences ...
By Renishaw plc
-
NDI Launches Deep Brain Innovations, LLC
NDI Medical, LLC, a venture and commercialization firm that funds and develops innovative neurodevice technologies, has launched its next portfolio company, Deep Brain Innovations, LLC (DBI). DBI will commercialize its groundbreaking technology that is designed to optimize deep brain stimulation (DBS) therapy for patients with Parkinson’s disease. Currently available DBS therapy is ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you